Citations (78)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Gustavo Guimarães Moreira Balbi, Vinicius Domingues, Gabriela Guimarães Moreira Balbi, Guilherme Ramires De Jesús & Roger Abramino Levy. (2019) Use of synthetic and biologic DMARDs during pregnancy. Expert Review of Clinical Immunology 15:1, pages 27-39.
Read now
Read now
Melissa B Hoffman, Michael Farhangian & Steven R Feldman. (2015) Psoriasis during pregnancy: characteristics and important management recommendations. Expert Review of Clinical Immunology 11:6, pages 709-720.
Read now
Read now
Giampiero Girolomoni, Gianfranco Altomare, Fabio Ayala, Enzo Berardesca, Piergiacomo Calzavara Pinton, Sergio Chimenti, Patrizia Martini, Andrea Peserico, Antonio Puglisi Guerra & Gino Antonio Vena. (2015) Differential management of mild-to-severe psoriasis with biologic drugs: An Italian Delphi consensus expert panel. Journal of Dermatological Treatment 26:2, pages 128-133.
Read now
Read now
Articles from other publishers (75)
Ken Lund, Olav Sivertsen Garvik, Signe Marie Aagaard, Line Riis Jølving, Michael Due Larsen, Per Damkier & Bente Mertz Nørgård. (2023) Paternal preconception exposure to non‐steroid anti‐inflammatory drugs or opioids and adverse birth outcomes: A nationwide registry‐based cohort study. Andrology.
Crossref
Crossref
Peter Zarén, Carl Turesson & Aleksander Giwercman. (2023) Methotrexate use among men—association with fertility and the perinatal health of their children: a Swedish nationwide register study. Fertility and Sterility.
Crossref
Crossref
Simone Forcato, Ana Beatriz de Oliveira Aquino, Lorena I. Borges, Maria Luiza Francisconi Lubanco Thomé, Júlia O. Bilibio, Hannah Hamada Mendonça Lens, Rafaela P. Erthal, Flávia A. Guarnier, Glaura Scantamburlo Alves Fernandes & Daniela Cristina Ceccatto Gerardin. (2023) Sulfasalazine exposure during pregnancy and lactation: reproductive outcomes in male rat offspring. Reproduction, Fertility and Development 35:8, pages 469-479.
Crossref
Crossref
Mark D Russell, Mrinalini Dey, Julia Flint, Philippa Davie, Alexander Allen, Amy Crossley, Margreta Frishman, Mary Gayed, Kenneth Hodson, Munther Khamashta, Louise Moore, Sonia Panchal, Madeleine Piper, Clare Reid, Katherine Saxby, Karen Schreiber, Naz Senvar, Sofia Tosounidou, Maud van de Venne, Louise Warburton, David Williams, Chee-Seng Yee, Caroline Gordon, Ian Giles, Ian Giles, Ed Roddy, Kate Armon, Lauren Astell, Caroline Cotton, Alan Davidson, Sarah Fordham, Claire Jones, Christopher Joyce, Anoop Kuttikat, Zoe McLaren, Karen Merrison, Devesh Mewar, Amanda Mootoo & Emma Williams. (2023) British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids. Rheumatology 62:4, pages e48-e88.
Crossref
Crossref
Wei Huang, Teng Wu, Tianyu Jin, Yuan Zhang, Jing Wang, Jiaping Qi, Yixuan Li, Huan Jiang, Ju Zhang, Zhaoyu Jiang, Lin Chen & Zhenhua Ying. (2022) Maternal and fetal outcomes in pregnant women with rheumatoid arthritis: a systematic review and meta-analysis. Clinical Rheumatology 42:3, pages 855-870.
Crossref
Crossref
Amandine Dernoncourt, Sophie Liabeuf, Youssef Bennis, Kamel Masmoudi, Sandra Bodeau, Solène Laville, Anne-Sophie Hurtel-Lemaire, Valérie Gras-Champel & Benjamin Batteux. (2022) Fetal and Neonatal Adverse Drug Reactions Associated with Biologics Taken During Pregnancy by Women with Autoimmune Diseases: Insights from an Analysis of the World Health Organization Pharmacovigilance Database (VigiBase®). BioDrugs 37:1, pages 73-87.
Crossref
Crossref
Nevena Rebić, Sarah Munro, Ria Garg, Glen Hazlewood, Neda Amiri, Corisande Baldwin, Stephanie Ensworth, Laurie Proulx & Mary A. De Vera. (2022) “The medications are the decision-makers…” Making reproductive and medication use decisions among female patients with rheumatoid arthritis: a constructivist grounded theory. Arthritis Research & Therapy 24:1.
Crossref
Crossref
Galina Balakirski, Sascha Gerdes, Stefan Beissert, Falk Ochsendorf, Ralph von Kiedrowski & Dagmar Wilsmann‐Theis. (2022) Psoriasis‐Therapie während Schwangerschaft und Stillzeit. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 20:5, pages 653-685.
Crossref
Crossref
Galina Balakirski, Sascha Gerdes, Stefan Beissert, Falk Ochsendorf, Ralph von Kiedrowski & Dagmar Wilsmann‐Theis. (2022) Therapy of psoriasis during pregnancy and breast‐feeding. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 20:5, pages 653-683.
Crossref
Crossref
Christina D. Chambers, Diana L. Johnson, Ronghui Xu, Yunjun Luo, Robert Felix, Minh Fine, Chloe Lessard, Margaret P. Adam, Stephen R. Braddock, Luther K. Robinson, Leah Burke, Kenneth Lyons Jones, D. Quinn, C. Stallman, K. Kao, K. Bertrand, J. Brochu, S. Lavigne, E. Conover, P. Cole, M. Roth, L. Harris‐Sagaribay, L. Wolfe, J. Carey, A. Romeo, A. Pupco, S. Ito & C. Coles. (2022) Birth Outcomes in Women Who Have Taken Hydroxycholoroquine During Pregnancy: A Prospective Cohort Study. Arthritis & Rheumatology 74:4, pages 711-724.
Crossref
Crossref
Simone Forcato, Ana Beatriz de Oliveira Aquino, Nathaly de Moura Camparoto, Hannah Hamada Mendonça Lens, Flávia Alessandra Guarnier, Ana Carolina Inhasz Kiss & Daniela Cristina Ceccatto Gerardin. (2022) Sulfasalazine exposure during pregnancy and lactation induces alterations in reproductive behavior in adult female rat offspring. Life Sciences 293, pages 120303.
Crossref
Crossref
Soumaya Boussaid, Yasmine Makhlouf, Sonia Rekik, Samia Jammali, Elhem Cheour, Hela Sahli, Mohamed Elleuch & Helmi Ben Saad. (2022) The effects of autoimmune rheumatic-related diseases on male reproductive health: A systematic review. Journal of Reproductive Immunology 150, pages 103472.
Crossref
Crossref
Claudia Massarotti, Elvira Sbragia, Irene Gazzo, Sara Stigliani, Matilde Inglese & Paola Anserini. (2021) Effect of Multiple Sclerosis and Its Treatments on Male Fertility: Cues for Future Research. Journal of Clinical Medicine 10:22, pages 5401.
Crossref
Crossref
Yvette Meißner & Anja Strangfeld. (2021) Erkenntnisse zu Schwangerschaft und Stillzeit bei entzündlich rheumatischen Erkrankungen durch BeobachtungsdatenInsights into pregnancy and breastfeeding in inflammatory rheumatic diseases through observational data. Zeitschrift für Rheumatologie 80:8, pages 733-742.
Crossref
Crossref
Kara M. De Felice & Sunanda Kane. (2021) Safety of anti-TNF agents in pregnancy. Journal of Allergy and Clinical Immunology 148:3, pages 661-667.
Crossref
Crossref
Yasser El Miedany & Deborah Palmer. (2021) Rheumatology-led pregnancy clinic: men perspective. Clinical Rheumatology 40:8, pages 3067-3077.
Crossref
Crossref
Krista F. Huybrechts, Brian T. Bateman, Yanmin Zhu, Loreen Straub, Helen Mogun, Seoyoung C. Kim, Rishi J. Desai & Sonia Hernandez-Diaz. (2021) Hydroxychloroquine early in pregnancy and risk of birth defects. American Journal of Obstetrics and Gynecology 224:3, pages 290.e1-290.e22.
Crossref
Crossref
Asmaa Beltagy, Azin Aghamajidi, Laura Trespidi, Wally Ossola & Pier Luigi Meroni. (2021) Biologics During Pregnancy and Breastfeeding Among Women With Rheumatic Diseases: Safety Clinical Evidence on the Road. Frontiers in Pharmacology 12.
Crossref
Crossref
Benjamin Yu, Anne L. Darves-Bornoz, Robert E. Brannigan & Joshua A. Halpern. (2020) Acute anejaculation, hypogonadism, and fertility preservation in the setting of neurosarcoidosis: case report and literature review. F&S Reports 1:3, pages 317-325.
Crossref
Crossref
Ibrahim Hammad & T. Flint Porter. (2020) An Update on Biologic Agents During Pregnancy. Clinics in Perinatology 47:4, pages 733-742.
Crossref
Crossref
Cristina Belizna, Pier Luigi Meroni, Yehuda Shoenfeld, Katrien Devreese, Jaume Alijotas-Reig, Enrique Esteve-Valverde, Cecilia Chighizola, Francesca Pregnolato, Hannah Cohen, Celine Fassot, Patrick Martin Mattera, Pascale Peretti, Alexandre Levy, Laurence Bernard, Mathilde Saiet, Laurence Lagarce, Marie Briet, Marianne Rivière, Isabelle Pellier, Géraldine Gascoin, Jose Rakotonjanahary, Maria Orietta Borghi, Ljudmila Stojanovich, Aleksandra Djokovic, Natasa Stanisavljevic, Rebecca Bromley, Elisabeth Elefant-Amoura, Nadia Bahi Buisson, Taylor Pindi Sala, Hilde Kelchtermans, Alexander Makatsariya, Viktoria Bidsatze, Jamilya Khizroeva, Jose Omar Latino, Sebastian Udry, Daniel Henrion, Laurent Loufrani, Anne Laure Guihot, Christian Muchardt, Milena Hasan, Marie Noelle Ungeheuer, Jan Voswinkel, Laura Damian, Ingrid Pabinger, Johanna Gebhart, Rosario Lopez Pedrera, Jan Willem Cohen Tervaert, Angela Tincani & Laura Andreoli. (2020) In utero exposure to Azathioprine in autoimmune disease. Where do we stand?. Autoimmunity Reviews 19:9, pages 102525.
Crossref
Crossref
Mehret Birru Talabi & Megan E.B. Clowse. (2020) Antirheumatic medications in pregnancy and breastfeeding. Current Opinion in Rheumatology 32:3, pages 238-246.
Crossref
Crossref
A. Mattuizzi, H. Madar, A. Froeliger, C. Houssin, P. Chabanier, B. Merlot, E. Lazaro, B. Elleboode & L. Sentilhes. (2020) Complications obstétricales du lupus érythémateux systémique et du SAPL : une prise en charge multidisciplinaire. Gynécologie Obstétrique Fertilité & Sénologie 48:5, pages 448-452.
Crossref
Crossref
Bonnie L. Bermas. (2020) Paternal safety of anti-rheumatic medications. Best Practice & Research Clinical Obstetrics & Gynaecology 64, pages 77-84.
Crossref
Crossref
Birgit Pfaller, Anna Pupco, Tom Leibson, Daniel Aletaha & Shinya Ito. (2019) A critical review of the reproductive safety of Leflunomide. Clinical Rheumatology 39:2, pages 607-612.
Crossref
Crossref
Eun-Jung ParkHyungjin KimSeung Min JungYoon-Kyoung SungHan Joo Baek & Jisoo Lee. (2020) The Use of Biological Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in Korea: Results of a Korean Expert Consensus. Journal of Rheumatic Diseases 27:1, pages 4.
Crossref
Crossref
Eun-Jung Park, Hyungjin Kim, Seung Min Jung, Yoon-Kyoung Sung, Han Joo Baek & Jisoo Lee. (2020) The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus. The Korean Journal of Internal Medicine 35:1, pages 41-59.
Crossref
Crossref
Mehret Birru Talabi, Megan E. B. Clowse, Susan J. Blalock, Galen Switzer, Lan Yu, Alaina Chodoff & Sonya Borrero. (2019) Development of ReproKnow, a reproductive knowledge assessment for women with rheumatic diseases. BMC Rheumatology 3:1.
Crossref
Crossref
Bente Mertz Nørgård, Line Riis Jølving, Michael Due Larsen & Sonia Friedman. (2019) Parental IBD and Long-term Health Outcomes in the Offspring. Inflammatory Bowel Diseases 25:8, pages 1339-1348.
Crossref
Crossref
Nicole Hunt & Mehret Birru Talabi. (2019) Family Planning and Rheumatoid Arthritis. Current Rheumatology Reports 21:5.
Crossref
Crossref
. (2019) ACOG Committee Opinion No. 776: Immune Modulating Therapies in Pregnancy and Lactation. Obstetrics & Gynecology 133:4, pages e287-e295.
Crossref
Crossref
Maria Mouyis, Julia D. Flint & Ian P. Giles. (2019) Safety of anti-rheumatic drugs in men trying to conceive: A systematic review and analysis of published evidence. Seminars in Arthritis and Rheumatism 48:5, pages 911-920.
Crossref
Crossref
Claudio Ponticelli & Gabriella Moroni. (2018) Fetal Toxicity of Immunosuppressive Drugs in Pregnancy. Journal of Clinical Medicine 7:12, pages 552.
Crossref
Crossref
M.C. Micu, M. Ostensen, P.M. Villiger, R. Micu & R. Ionescu. (2018) Paternal exposure to antirheumatic drugs—What physicians should know: Review of the literature. Seminars in Arthritis and Rheumatism 48:2, pages 343-355.
Crossref
Crossref
Ian M. Ward & Amanda Knott. (2018) Practical Pearls About Current Rheumatic Medications. Primary Care: Clinics in Office Practice 45:2, pages 193-212.
Crossref
Crossref
. 2017. High-Risk Pregnancy. High-Risk Pregnancy.
Piyush Kumar, Anupam Das, NiharikaRanjan Lal, Sourabh Jain & Anupama Ghosh. (2018) Safety of important dermatological drugs (retinoids, immune suppressants, anti androgens and thalidomide) in reproductively active males with respect to pregnancy outcome: A brief review of literature. Indian Journal of Dermatology, Venereology and Leprology 84:5, pages 539.
Crossref
Crossref
Michael Due Larsen, Sonia Friedman, Bjarne Magnussen & Bente Mertz Nørgård. (2018) Birth Outcome of Children Fathered by Men Treated with Systemic Corticosteroids during the Conception Period - A Cohort Study based on Nationwide Data. Basic & Clinical Pharmacology & Toxicology 122:1, pages 133-138.
Crossref
Crossref
Rachel W. Winter, Michael Due Larsen, Bjarne Magnussen, Sonia Friedman, Heidi Kammerlander & Bente Mertz Nørgård. (2017) Birth outcomes after preconception paternal exposure to methotrexate: A nationwide cohort study. Reproductive Toxicology 74, pages 219-223.
Crossref
Crossref
Corinna Weber-Schoendorfer, Evelin Beck, Tatjana Tissen-Diabaté & Christof Schaefer. (2017) Leflunomide – A human teratogen? A still not answered question. An evaluation of the German Embryotox pharmacovigilance database. Reproductive Toxicology 71, pages 101-107.
Crossref
Crossref
P A Shesternya, M M Petrova & A O Vasilyeva. (2017) New horizons in the use of biological agents during pregnancy in patients with rheumatic disease. Terapevticheskii arkhiv 89:5, pages 105-112.
Crossref
Crossref
F.M. Garritsen, M.P.H. van den Broek, A.D. van Zuilen, H.H. Fidder, M.S. de Bruin-Weller & P.I. Spuls. (2017) Pregnancy and fetal outcomes after paternal exposure to azathioprine, methotrexate or mycophenolic acid: a critically appraised topic. British Journal of Dermatology 176:4, pages 866-877.
Crossref
Crossref
Helen Elizabeth Ritchie, Diana Joy Oakes, Elizabeth Hegedus, Majella Hill & Debra Kennedy. (2017) Counselling regarding paternal exposures: Can we do better?. Australian and New Zealand Journal of Obstetrics and Gynaecology 57:2, pages 162-167.
Crossref
Crossref
Anne Grosen, Jens Kelsen, Christian Lodberg Hvas, Emanuelle Bellaguarda & Stephen B. Hanauer. (2017) The Influence of Methotrexate Treatment on Male Fertility and Pregnancy Outcome After Paternal Exposure. Inflammatory Bowel Diseases 23:4, pages 561-569.
Crossref
Crossref
Lasse Karlsen Eck, Thomas Bo Jensen, Dimitrios Mastrogiannis, Arendse Torp-Pedersen, Bjarke Askaa, Torben Kjær Nielsen, Henrik Enghusen Poulsen, Espen Jimenez-Solem & Jon Trærup Andersen. (2017) Risk of Adverse Pregnancy Outcome After Paternal Exposure to Methotrexate Within 90 Days Before Pregnancy. Obstetrics & Gynecology 129:4, pages 707-714.
Crossref
Crossref
Jeanette R. Carpenter & D. Ware Branch. 2017. Obstetrics: Normal and Problem Pregnancies. Obstetrics: Normal and Problem Pregnancies
981
997
.
Michael Due Larsen, Sonia Friedman, Bjarne Magnussen & Bente Mertz Nørgård. (2016) Birth Outcomes in Children Fathered by Men Treated with Anti-TNF-α Agents Before Conception. American Journal of Gastroenterology 111:11, pages 1608-1613.
Crossref
Crossref
Roger A. Levy, Guilherme R. de Jesús, Nilson R. de Jesús & Evandro M. Klumb. (2016) Critical review of the current recommendations for the treatment of systemic inflammatory rheumatic diseases during pregnancy and lactation. Autoimmunity Reviews 15:10, pages 955-963.
Crossref
Crossref
Carina Götestam Skorpen, Maria Hoeltzenbein, Angela Tincani, Rebecca Fischer-Betz, Elisabeth Elefant, Christina Chambers, Josè da Silva, Catherine Nelson-Piercy, Irene Cetin, Nathalie Costedoat-Chalumeau, Radboud Dolhain, Frauke Förger, Munther Khamashta, Guillermo Ruiz-Irastorza, Angela Zink, Jiri Vencovsky, Maurizio Cutolo, Nele Caeyers, Claudia Zumbühl & Monika Østensen. (2016) The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Annals of the Rheumatic Diseases 75:5, pages 795-810.
Crossref
Crossref
Wendy Marder, Emily A. Littlejohn & Emily C. Somers. (2016) Pregnancy and autoimmune connective tissue diseases. Best Practice & Research Clinical Rheumatology 30:1, pages 63-80.
Crossref
Crossref
Junie P. Warrington, Heather A. Drummond, Joey P. Granger & Michael J. Ryan. (2015) Placental ischemia-induced increases in brain water content and cerebrovascular permeability: role of TNF-α. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 309:11, pages R1425-R1431.
Crossref
Crossref
S.M. Ranchhod, K.C. Gunn, T.M. Fowke, J.O. Davidson, C.A. Lear, J. Bai, L. Bennet, C. Mallard, A.J. Gunn & J.M. Dean. (2015) Potential neuroprotective strategies for perinatal infection and inflammation. International Journal of Developmental Neuroscience 45:1, pages 44-54.
Crossref
Crossref
Nurit Katz-Agranov, Saakshi Khattri & Gisele Zandman-Goddard. (2015) The role of intravenous immunoglobulins in the treatment of rheumatoid arthritis. Autoimmunity Reviews 14:8, pages 651-658.
Crossref
Crossref
Patricia Shu Kurizky, Clarissa de Castro Ferreira, Lucas Souza Carmo Nogueira & Licia Maria Henrique da Mota. (2015) Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding. Anais Brasileiros de Dermatologia 90:3, pages 367-375.
Crossref
Crossref
Corinna Weber-Schöndorfer. 2015. Drugs During Pregnancy and Lactation. Drugs During Pregnancy and Lactation
341
372
.
Candice Yuvienco & Kerri Batra. 2015. Medical Management of the Pregnant Patient. Medical Management of the Pregnant Patient
275
317
.
Marianne Wallenius, Elisabeth Lie, Anne K. Daltveit, Kjell Å. Salvesen, Johan F. Skomsvoll, Synøve Kalstad, Åse S. Lexberg, Knut Mikkelsen, Tore K. Kvien & Monika Østensen. (2015) Brief Report: No Excess Risks in Offspring With Paternal Preconception Exposure to Disease-Modifying Antirheumatic Drugs. Arthritis & Rheumatology 67:1, pages 296-301.
Crossref
Crossref
Zivanit Ergaz, Benjamin Bar-Oz, Gilad W. Vainer, Sinan Abu-Leil, Natalia Simanovsky & Orna Diav-Citrin. (2014) Congenital fulminant Kaposiform hemangioendothelioma of the leg. Reproductive Toxicology 50, pages 1-3.
Crossref
Crossref
V. Ruiz, E. Manubens & L. Puig. (2014) Psoriasis In Pregnancy: A Review (II). Actas Dermo-Sifiliográficas (English Edition) 105:9, pages 813-821.
Crossref
Crossref
V. Ruiz, E. Manubens & L. Puig. (2014) Psoriasis y embarazo: revisión (II). Actas Dermo-Sifiliográficas 105:9, pages 813-821.
Crossref
Crossref
Marvin Williams & Eliza F. Chakravarty. (2014) Rheumatoid arthritis and pregnancy. Current Opinion in Rheumatology 26:3, pages 341-346.
Crossref
Crossref
C. Weber-Schoendorfer, M. Hoeltzenbein, E. Wacker, R. Meister & C. Schaefer. (2013) No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study. Rheumatology 53:4, pages 757-763.
Crossref
Crossref
Ashley L. Semble, Scott A. Davis & Steven R. Feldman. (2013) Safety and Tolerability of Tumor Necrosis Factor-α Inhibitors in Psoriasis: A Narrative Review. American Journal of Clinical Dermatology 15:1, pages 37-43.
Crossref
Crossref
Tiziana Cotechini, Maria Komisarenko, Arissa Sperou, Shannyn Macdonald-Goodfellow, Michael A. Adams & Charles H. Graham. (2014) Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia. Journal of Experimental Medicine 211:1, pages 165-179.
Crossref
Crossref
Orna Diav-Citrin, Anna Otcheretianski-Volodarsky, Svetlana Shechtman & Asher Ornoy. (2014) Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: A prospective, comparative, observational study. Reproductive Toxicology 43, pages 78-84.
Crossref
Crossref
Sonia Friedman, Thomas F. McElrath & Jacqueline L. Wolf. (2013) Management of Fertility and Pregnancy in Women with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 19:13, pages 2937-2948.
Crossref
Crossref
J. S. Chen, J. B. Ford, C. L. Roberts, J. M. Simpson & L. M. March. (2013) Pregnancy outcomes in women with juvenile idiopathic arthritis: a population-based study. Rheumatology 52:6, pages 1119-1125.
Crossref
Crossref
Monika Østensen & Frauke Förger. (2013) How safe are anti-rheumatic drugs during pregnancy?. Current Opinion in Pharmacology 13:3, pages 470-475.
Crossref
Crossref
Anders Engeland, Tone Bjørge, Anne Kjersti Daltveit, Svetlana Skurtveit, Siri Vangen, Stein Emil Vollset & Kari Furu. (2013) Effects of preconceptional paternal drug exposure on birth outcomes: cohort study of 340 000 pregnancies using Norwegian population-based databases. British Journal of Clinical Pharmacology 75:4, pages 1134-1141.
Crossref
Crossref
Jon Trærup Andersen, Morten Petersen, Espen Jimenez-Solem, Jeppe Nørgaard Rasmussen, Nadia Lyhne Andersen, Shoaib Afzal, Kasper Broedbaek, Brian Rafn Hjelvang, Lars Køber, Christian Torp-Pedersen & Henrik Enghusen Poulsen. (2013) Trimethoprim Use prior to Pregnancy and the Risk of Congenital Malformation: A Register-Based Nationwide Cohort Study. Obstetrics and Gynecology International 2013, pages 1-8.
Crossref
Crossref
Diana Sorin, Lev Pavlovsky & Michael David. (2012) Psoriasis in Pregnancy. Current Dermatology Reports 1:4, pages 209-213.
Crossref
Crossref
&NA;. (2012) The treatment of rheumatoid arthritis in pregnant women requires careful strategies before, during and after pregnancy. Drugs & Therapy Perspectives 28:11, pages 19-22.
Crossref
Crossref
. (2012) The treatment of rheumatoid arthritis in pregnant women requires careful strategies before, during and after pregnancy. Drugs & Therapy Perspectives 28:11, pages 19-22.
Crossref
Crossref
. (2012) No increase in congenital malformations with DMARDs. Nature Reviews Rheumatology 8:5, pages 246-246.
Crossref
Crossref
Simone Forcato, Ana de Oliveira Aquino, Nathaly de Moura Camparoto, Hannah Mendonça Lens, Flávia Guarnier, Ana Inhasz Kiss & Daniela Ceccatto Gerardin. (2021) Can Maternal Treatment with Sulfasalazine During Gestation and Lactation Cause Reproductive Disorders in Female Rat Offspring?. SSRN Electronic Journal.
Crossref
Crossref